BioSpace News Archive

Alkermes announced the company awarded $1 million in grants to national and local non-profit community organizations for the implementation of innovative, high-impact and replicable programs designed to support people affected by mental health and substance use disorders.

Revenue from continuing operations was $464.2 million, an increase of 9.0% from $425.7 million in the third quarter of 2016.

The FDA considers the resubmission to be filed as of October 24, 2017, with a PDUFA action date of April 24, 2018.

Mylan is one of the largest suppliers of cancer medicines by volume in the U.S., with a robust oncology portfolio of more than 40 products.

Total net revenues for the three months ended September 30, 2017 were approximately $916,000, compared to approximately $475,000 for the three months ended September 30, 2016.

Tetra has received its first sales order from Sante Cannabis.

Center for Device Innovation @ Texas Medical Center to be Led by Acclaimed Surgeon and Entrepreneur Billy Cohn, M.D. [09-November-2017] HOUSTON, Nov. 9, 2017 /PRNewswire/ -- Johnson & Johnson Medical Devices Companies (JJMDC)* today opened the Center for Device Innovation at the Texas Medical Center (CDI @ TMC), a broad, innovative collaboration with John

The Hizentra PATH study is the largest controlled clinical study in patients with CIDP.

CyclASol potentially overcomes the current intolerability and efficacy profiles due to the benefits of a water-free vehicle and the mechanism of drug delivery.

Revenue for the three months ended September 30, 2017 was $14.0 million, an increase of $8.4 million, or 149%, as compared to $5.6 million for the three months ended September 30, 2016.